Ryanair Holdings PLC Transaction in Own Shares

RNS Number : 2773O

Ryanair Holdings PLC

02 December 2024

 

Ryanair Holdings plc

Transaction in own shares

Ryanair Holdings plc (the "Company") today announces that on Friday, 29 November 2024 it purchased for cancellation a total of 73,275 ordinary shares of nominal value €0.006 each in the capital of the Company ("Ordinary Shares") and 99,626 Ordinary Shares underlying the American Depositary Shares, as further detailed below.

	Per Ordinary Share	Per Ordinary Share underlying American Depositary Shares
Volume weighted average price paid	€18.3376	US$22.0621
Highest price paid	€18.655	US$22.185
Lowest price paid	€18.200	US$21.935

 

These share purchases form part of the Company's existing share buy-back programme, details of which were announced on 27 August 2024 (the "Programme").

As announced on 27 August 2024, all shares purchased by the Company will be cancelled. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), a schedule of individual trades by J&E Davy on behalf of the Company as part of the Programme is outlined in this announcement below.

Enquiries:

Contact:

Peter Larkin

Ryanair Holdings Plc

Tel: + 353 1 945 1212

 

Schedule of Trades:

 

	Issuer name:				Ryanair Holdings plc
	LEI				635400BR2ROC1FVEBQ56
	ISIN:				IE00BYTBXV33
	Intermediary name:				J&E Davy
	Intermediary code:				DAVYIE21
	Time zone:				GMT
	Currency:				EUR
Number of Shares		Gross Price per Share		Currency		Trade Time	Exchange	Trade ID
11022		18.2		EURO		09:50:00	Euronext Dublin	00043469215TRLO0-1
3014		18.24		EURO		10:14:16	Euronext Dublin	00043469480TRLO0-1
2000		18.25		EURO		10:21:22	Euronext Dublin	00043469580TRLO0-1
19566		18.295		EURO		10:45:59	Euronext Dublin	00043469862TRLO0-1
6441		18.3		EURO		12:08:19	Euronext Dublin	00043470774TRLO0-1
22112		18.345		EURO		12:58:39	Euronext Dublin	00043471218TRLO0-1
9120		18.655		EURO		15:53:21	Euronext Dublin	00043475161TRLO0-1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

ISELFLFBZLLBFBE